Coping with Multiple Sclerosis

Home > Coping with Multiple Sclerosis > The Search for Causes, Treatments, and a Cure

The Search for Causes, Treatments, and a Cure

21 Articles found
The Importance of Clinical Trials
The Search For A Cause of MS
MS and Autoimmune Thyroiditis
Making Sense of MS Research (Transcript)
The Genetic Connection
Shades of Gray: MS Misconceptions, Misunderstandings, and Misinterpretations
15 Years of MS Therapy
What About the Side Effects?
Oral Medications for MS Treatment
The Potential Role of Chemokines in Remyelination
The Medication Solution Assists in Restoring Emotional Health
Fampridine SR - One Step Closer to Becoming a Reality
Exploring Our Differences: African Americans and MS
When Medication Stops Working or Causes Complications: It's Time to Switch
The Changing Face of MS
Examining the Ampyra™Experience By: Daniel Kantor, M.D.
Emergies Therapies Teleconference with Dr. Aaron Boster
LDN: Miracle or Myth?
The Next Chapter in MS Care
Prescription Pain Relief
What to Expect from Your MS Disease-Modifying Drug

112 News found
03/23/2015     New molecule may lead to inflammation inhibitor
03/06/2015     Study: Genetic variant may be MS risk factor
03/02/2015     Nutrient levels may be key ingredient for MS patients
03/02/2015     New study suggests coffee, reduced MS risk link
02/19/2015     Researcher seeks minorities with MS for survey
02/12/2015     Stem cell treatment outperforms mitoxantrone in reducing new lesions
02/10/2015     Documentation of MS progression may lead to new treatment options
02/02/2015     Biogen, Google team up in MS effort
01/27/2015     iConquerMS initiative offers introductory webinar
01/23/2015     Cell transplant therapy shows improvement in MS disability
01/12/2015     Studies erode vaccination, MS link
01/08/2015     Study: Two years most effective measure of NEDA status
01/05/2015     Stem cell therapy may hold key to MS treatment
12/08/2014     Study: Rogue proteins may be linked to MS
12/02/2014     Fingolimod trial for PPMS does not meet primary endpoint
12/01/2014     iConquerMS offers Big Data enhancement to MS research
11/24/2014     Immune programming cells may hold key to new treatments
11/20/2014     Study: Myelin mouse model may not apply to humans
11/15/2014     Lemtrada Receives FDA Approval for MS
11/12/2014     Study: Key protein reduces MS severity in mice
11/05/2014     First patient enrolls in Phase II trial to evaluate vatelizumab
10/31/2014     New study links immune system, MS cause
10/28/2014     Biogen reports death of patient taking Tecfidera
10/22/2014     Study finds no long-term link between vaccines, MS
10/09/2014     Harvard Mindfulness Lab seeks participants for MS study
09/25/2014     Study finds processing speed, cognitive deficit link
09/22/2014     New drug candidate shows promise in treating MS
09/10/2014     Refined MRI technique finds link between gray matter demyelination and MS severity
09/09/2014     Scientists find MS, intestinal barrier link
09/03/2014     Immune cell conversion may hold key to new MS treatments
08/29/2014     Researchers find salt intake, MS link
08/28/2014     Wii training may help MS patients regain balance
08/18/2014     FDA approves Plegridy for MS patients
08/14/2014     Researcher finds possible incompatibility between MS, HIV
07/15/2014     Cleveland Clinic Uses iPad as Assessment Tool for MS Patients
07/15/2014     Teva Tries to Combat Generic Drug Competition
06/18/2014     Audio Available from MS Research Update Teleconference
04/07/2014     Genzyme to Resubmit Lemtrada™ Application for FDA Review
04/03/2014     Supreme Court to Rule on Copaxone® Patent Dispute
03/19/2014     Plegridy™ Review Extended for Three Months
02/14/2014     Blocking Protein Could Lead to Myelin Repair
02/04/2014     FDA Approves Three-Times-a-Week Copaxone 40mg/mL
01/14/2014     Grant to Study Effectiveness of Vitamin A in Treating MS
01/13/2014     Antioxident Shows Promise in Fight Against MS
01/03/2014     Lemtrada™ Fails to win Approval
12/31/2013     MRI Method for Measuring MS Progression Validated
12/18/2013     Molecular Sensor May Detect MS Prior to Symptoms
12/18/2013     Study Suggests Vitamin D Alters Course of Harmful Cells
12/05/2013     Vaccine to Prevent MS Shows Promise in Small Study
12/05/2013     University Receives Major Grant to Study Cognitive Intervention
11/08/2013     Bacterium may Trigger MS
10/02/2013     Study Refines Genetic Landscape of MS
08/14/2013     FDA Approves Neural Stem Cell Clinical Trial
05/06/2013     MS Risk Appears to be Higher for African Americans than Caucasians
03/27/2013     Oral Medication Tecfidera™ Approved for Relapsing MS
03/21/2013     Breaking News from AAN 65th Annual Meeting
01/24/2013     Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule
01/04/2013     Rebif Single-Use Auto-Injector Approved
11/19/2012     Re-Educating Immune Cells May Halt MS Progression
11/05/2012     Blocking Enzyme May Allow Remylination
09/21/2012     Latest BG-12 Trial Results Show Significant Benefit
09/13/2012     Another Oral Medication Approved for Relapsing MS
07/18/2012     Interferon Beta May not Slow MS Progression According to New Study
06/18/2012     Study Identifies Gene Linked to Vitamin D Deficiency
06/14/2012     Fertility Treatment Tied to Higher Relapse Rate in Women with MS
06/13/2012     Another MS Drug Application Submitted for FDA Approval
06/12/2012     Video Coverage of the European Neurological Society 2012 Meeting
05/10/2012     FDA Alerts on Potential Dangers of “Liberation Therapy” for CCSVI
04/24/2012     Novartis Updates U.S. Label on Gilenya®
04/16/2012     Gilenya® Role in PML Diagnosis Unclear
03/08/2012     Pregnancy May Cut Risk of Developing MS
02/28/2012     BG-12 New Drug Application Submitted
01/20/2012     European Medicines Agency Strengthens Gilenya Guidelines While Review Underway
12/12/2011     Investigation Underway into Death of Gilenya Patient
12/09/2011     Genetic Clue to MS Identified
12/08/2011     Brain Biopsies Yield Clues to MS Course
10/31/2011     Friendly Gut Bacteria May Play Role in Triggering MS
10/26/2011     BG-12 Moves Forward with Positive Data from Late-Stage Trials
10/18/2011     Circadian Disruption may Contribute to MS Development in Youth
08/17/2011     Research Identifies How Vitamin D Combats MS
08/16/2011     Anti-Inflammatory Agents Silence Overactive Immune Response
08/11/2011     Number of Genes Linked to MS More than Doubles
06/10/2011     Study Suggests Shingles Nearly Quadruples MS Risk in Asia
06/08/2011     Research Examines Cellular Events that May Lead to MS
05/19/2011     Estrogen Receptors Play Anti-Inflammatory Role in the Brain
04/27/2011     Blocking Crucial Molecule Could Help Treat Multiple Sclerosis
04/27/2011     Common Virus Plus Low Sunlight Exposure May Increase Risk of Multiple Sclerosis
04/13/2011     Gilenya™ Reduces Risk of MS Disability Progression Regardless of Treatment History
04/13/2011     New Study Results Cast Doubt on Theory that CCSVI Causes MS
04/12/2011     Late-Stage Trial of Oral BG-12 for Relapsing-Remitting MS Shows Postive Results
04/11/2011     Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability in Long-Term Study
03/24/2011     Stem Cells May Show Promise for People with Rapidly Progressing MS
02/24/2011     Warmer Weather Hampers Thinking Skills in People with MS
02/17/2011     Study Results Provide More Clues to Understanding the Pathology of MS
02/11/2011     More evidence that Vitamin D affects MS risk
01/20/2011     Plasma Exchange Effective In Treating Severe MS Relapses
11/24/2010     Toxin and Potential MS Treatment Focus of Research
11/19/2010     Researchers Make Surprising Discovery While Testing MS Pain Remedy
09/22/2010     First Oral Treatment for MS Approved by FDA
08/04/2010     New Studies Fail to Link CCSVI and MS
07/20/2010     Gut Bacteria and the MS Connection
06/30/2010     Study of “Liberation Treatment” to Launch in Buffalo
06/11/2010     Gilenia Gets Stamp of Approval From Advisory Panel to FDA
06/10/2010     Steroids Reduce Postpartum Relapses in Study
05/03/2010     Biomarkers Test for MS Nine Years Before Symptoms Appear
03/11/2010     FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers
03/10/2010     Study Implicates Epstein-Barr Virus in Development of MS
02/16/2010     Study Combining Daclizumab with Interferon Beta Treatment Brings Positive Results
02/10/2010     One of First CCSVI Studies Releases Preliminary Results
08/17/2009     Novartis Version of Betaseron to Hit Market This Fall
06/03/2009     Diabetes Drug Shows Potential in Treating MS
06/03/2009     Share Your Health Care Story

No Videos found

14 Audios found
Deciding Which Disease Modifiying Therapy is Right for You with Dr. Daniel Kantor - March 5th, 2013 Teleconference.
MS Treatments and Symptom Management with Dr. Daniel Kantor - March 13th, 2012 Teleconference
Emerging Therapies Teleconference with Dr. Aaron Boster - March 2nd, 2011 Teleconference
Emerging Therapies Teleconference with Dr. Aaron Boster - March 3rd, 2011 Teleconference
The Medication Solution Assists in Restoring Emotional Health
The Changing Face of MS
Exploring Our Differences: African Americans and MS
When Your Medication Stops Working or Causes Complications: It's Time to Switch
Fampridine SR - One Step Closer to Becoming a Reality
The Potential Role of Chemokines in Remyelination
What About the Side Effects?
Shades of Gray: MS Misconceptions, Misunderstandings, and Misinterpretations
MS Drugs in the Pipeline
Connectivity Among Autoimmune Diseases,Including MS

  Programs & Activities
Learn about the educational programs offered by the MSF or apply for services available to MS patients and their families.
get involved now 

  MS Community
Connect with others whose lives are affected by multiple sclerosis, whether it be from living with MS, caring for a loved one, or supporting the MS cause.
connect with others 

Unless otherwise specified, all medical content is compiled by MSF staff and reviewed for accuracy by a member of our Medical Advisory Board.

The MSF strives to present clear and unbiased information. This site is partially funded through a grant from Bayer Healthcare, LLC.

Website Design by SimplexWeb

© Copyright 2000-2013 Multiple Sclerosis Foundation - All Rights Reserved

リモワ リモワ アウトレット リモワ アウトレットモール リモワ アウトレット店舗 リモワ アウトレット 本物 リモワ アウトレット ドイツ リモワ アウトレット店 リモワ アウトレット 楽天 リモワ クラシックフライト リモワ クラシックフライト tsa リモワ クラシックフライト 63l リモワ クラシックフライト 35l リモワ クラシックフライト 2輪 リモワ クラシックフライト 激安 リモワ クラシックフライト 黒 リモワ クラシックフライト トパーズ リモワ クラシックフライト アタッシュケース リモワクラシックフライト 機内持ち込み リモワ クラシック rimowa クラシックフライト リモワクラシックフライト ユナイテッドアローズ リモワ フライト リモワ サルサ リモワ サルサエアー リモワ サルサデラックス リモワ サルサ ユナイテッドアローズ リモワ サルサ 86l リモワ サルサ 35l リモワ サルサ 激安 リモワ サルサエアー 34l リモワ サルサ 赤 リモワサルサ スーツケース リモワサルサ レッド リモワのサルサ リモワ サルサエアー 94l リモワ サルサエアー 63l リモワ サルサエアー 35l リモワ サルサエアー 84 リモワ サルサエアー ホワイト リモワ サルサエアー 20l リモワ サルサエアー 持ち手 リモワ サルサ エアー 激安 リモワサルサエアー ルビー リモワ サルサ エアー ネイビー リモワサルサエアー レンタル リモワ スーツケース リモワ スーツケース レンタル リモワ スーツケース サルサ リモワ スーツケース 機内持ち込み リモワ スーツケース 販売店 リモワ スーツケース 白 リモワ スーツケース 店舗 リモワ スーツケース カバー リモワスーツケース 激安 リモワスーツケース アウトレット rimowa スーツケース リモワ トパーズ リモワ トパーズ ステルス リモワ トパーズ チタニウム リモワ トパーズ 82l リモワ トパーズ 32l リモワ トパーズ プレミアム リモワ トパーズ 63l リモワ トパーズ 64l リモワ トパーズ 最安値 リモワ トパーズ 激安 リモワ トパーズ 35l リモワ トパーズ ゴールド リモワ トパーズ スーツケース リモワ リモワ 機内持ち込み リモワ リンボ リモワ ビジネストローリー リモワ スーツケース リモワ アウトレット リモワ 激安 リモワスーツケース rimowa rimowa激安 リモワ 通販 リモワ スーツケース 通販 リモワ リモワ サルサ リモワ トパーズ リモワ 機内持ち込み リモワ クラシックフライト リモワ サルサデラックス リモワ サルサエアー リモワ リンボ リモワ ビジネストローリー リモワ サルサ 激安 リモワ スーツケース リモワ リモワ アウトレット リモワスーツケース アウトレット リモワ 激安 リモワスーツケース リモワ サルサ rimowa rimowa激安 リモワ リモワ サルサ リモワ スーツケース リモワ 激安 リモワ サルサエアー リモワ アウトレット リモワ クラシックフライト リモワ 通販 リモワ スーツケース 通販